Dr. Clancy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave., Ml 2021
Cincinnati Children's Hospital
Cincinnati, OH 45229Phone+1 513-636-6771Fax+1 513-636-4615- Is this information wrong?
Education & Training
- University of Alabama Medical CenterFellowship, Pediatric Pulmonology, 1993 - 1996
- University of Virginia Medical CenterResidency, Pediatrics, 1990 - 1993
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990
Certifications & Licensure
- OH State Medical License 2011 - 2021
- AL State Medical License 1993 - 2011
Clinical Trials
- PTC124 for Cystic Fibrosis Start of enrollment: 2005 Sep 01
- Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa Start of enrollment: 2008 Jan 01
- Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis.Theodore G Liou, Natalia Argel, Fadi Asfour, Perry S Brown, Barbara A Chatfield, David R Cox, Cori L Daines, Dixie Durham, Jessica A Francis, Barbara Glover, My Helms,...> ;Iscience. 2024 Mar 15
- 1 citationsBuilt environment factors predictive of early rapid lung function decline in cystic fibrosis.Emrah Gecili, Cole Brokamp, Erika Rasnick, Pedro M Afonso, Eleni-Rosalina Andrinopoulou, Judith W Dexheimer, John P Clancy, Ruth H Keogh, Yizhao Ni, Anushka Palipana, ...> ;Pediatric Pulmonology. 2023 May 1
- 108 citationsClinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis.David P. Nichols, Alex C Paynter, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick, Steven D. Freedman, Daniel Gelfond, Lucas R. Hoffman, Andrea Kelly, Michael...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Nov 16
- Join now to see all
Grant Support
- Clinical CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- Phase 3 Study Evaluating Aztreonam Lysiante For Inhalation In Cystic FibrosisNational Center For Research Resources2007
- Eur-1009-MNational Center For Research Resources2007
- Eur-1008-MNational Center For Research Resources2007
- PTCNational Center For Research Resources2006–2007
- Long-Term Continuation Study Of Patients With Infantile-Onset Pompe DiseaseNational Center For Research Resources2006–2007
- Myozyme In Patients With Infantile-Onset Pompe DiseaseNational Center For Research Resources2005–2007
- Treatment In Patients <6 Months Old With Infantile-Onset Pompe Disease (1602)National Center For Research Resources2006
- Induced Sputum As A Tool To Evaluate Anti-Inflammatory Agents In CF PatientsNational Center For Research Resources2005–2006
- Pompe 1602National Center For Research Resources2005
- Oral Theraclec Tm-Total In CF Subjects With Exocrine Pancreatic InsufficiencyNational Center For Research Resources2005
- A Multicenter, Phase II Study Of Aerosolized Tgaavcf For The Treatment Of CFNational Center For Research Resources2005
- PH. II Study Of Aerosolized Tgaavcf For Treatment Of CFNational Center For Research Resources2004
- Open-Label Safety And Tolerability Study Of TheraclecNational Center For Research Resources2004
- Nebulized Aztreonam In CF PatientsNational Center For Research Resources2004
- Regulation Of CFTR By Adenosine, A2 Receptors, And PLA2National Heart, Lung, And Blood Institute2001–2004
- Pilot--Pseudovirion Vectors For CFTR DeliveryNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
Hospital Affiliations
- Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: